M. Uggowitzer et al., SONOGRAPHIC EVALUATION OF FOCAL NODULAR HYPERPLASIAS (FNH) OF THE LIVER WITH A TRANSPULMONARY GALACTOSE-BASED CONTRAST AGENT (LEVOVIST), British journal of radiology, 71(850), 1998, pp. 1026-1032
Focal nodular hyperplasias (FNH) are hypervascular, benign focal liver
lesions. Differentiation of FNH from other focal liver lesions is of
clinical importance. The purpose of this study was to examine the impa
ct of a new, transpulmonary echo-enhancing agent SHU 508A (Levovist) a
nd recent Doppler techniques in the sonographic evaluation of FNH. 43
patients with 61 focal nodular hyperplasias of the liver were examined
with grey scale ultrasound and power Doppler ultrasound. Levovist, a
galactose-air-microbubble suspension was administered intravenously in
all patients, either by bolus injection (400 mg ml(-1)) or continuous
pump-infusion (300 mg ml(-1)). Visualization of the feeding vessels a
nd vascularity of the lesions were evaluated. The resistance indexes (
RI) in the feeding vessel and the hepatic artery were assessed and com
pared with the diameters of the FNH. The mean diameter of FNH was 4.3
cm (+/-1.0). Echo enhanced power Doppler ultrasound was superior to un
enhanced power Doppler ultrasound in the detection of the feeding arte
ry (85% vs 98%) in FNH and depicted the internal vascular architecture
more clearly, especially in lesions located in the left lobe of the l
iver. Lesions smaller than 3 cm did not show a characteristic vascular
architecture with echo enhanced Doppler ultrasound. The resistance in
dex of the feeding artery (mean: 0.51 +/- 0.08) is significantly (p<0.
0001) lower than that of the hepatic artery (mean 0.65 +/- 0.06) with
a mean difference of -0.14 +/- 0.01 in the same patient. The RI of the
feeding artery significantly decreased as the size of the FNH increas
ed, whereas RI differences between the hepatic artery and the feeding
artery increased with lesion size. Intravenous (iv) bolus injection of
the contrast agent will depict the hypervascular nature of FNH more c
learly than iv infusion, although the latter will significantly prolon
g the diagnostic window. In conclusion, iv infusion of Levovist improv
es the visualization of the feeding artery and the radiating vascular
architecture in FNH located in the left lobe of the liver due to impro
ved signal-to-noise ratio and results in more effective suppression of
motion artefacts. Although echo enhanced Doppler ultrasound improves
the detection of the low resistance arterial feeding vessel in small F
NH, it will not, however, reveal a specific vascular pattern in these
lesions.